Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis
Fig 10
Faster growth of drug-resistant bacterial strains due to incomplete drug therapy.
Comparison of growth of rifampin mono-resistant bacterial strain during treatment of TB infection, with standard drug therapy (2HREZ/4HR) vs. therapy excluding isoniazid. Based on simulation of 5000 patients. Infection occurs on day -180, and drug therapy is started on day 0.